Induction of Tau Pathology by Intracerebral Infusion of Amyloid-β-Containing Brain Extract and by Amyloid-β Deposition in APP × Tau Transgenic Mice
Top Cited Papers
- 1 December 2007
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 171 (6) , 2012-2020
- https://doi.org/10.2353/ajpath.2007.070403
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branchesNature Neuroscience, 2004
- Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosisNature Neuroscience, 2004
- Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the ProteasomeNeuron, 2004
- In VivoAssessment of Brain Interstitial Fluid with Microdialysis Reveals Plaque-Associated Changes in Amyloid-β Metabolism and Half-LifeJournal of Neuroscience, 2003
- Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau ProteinJournal of Neuroscience, 2002
- Exogenous induction of cerebral β-amyloidosis in βAPP-transgenic micePeptides, 2002
- Amyloid-Associated Neuron Loss and Gliogenesis in the Neocortex of Amyloid Precursor Protein Transgenic MiceJournal of Neuroscience, 2002
- β-Amyloid fibrils induce tau phosphorylation and loss of microtubule bindingNeuron, 1995
- Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionatorThe Anatomical Record, 1991
- Silver staining of Alzheimer's neurofibrillary changes by means of physical development.1971